Alan Nurden: Comparing Antiplatelet and Antithrombin Therapies in Coronary Microcirculation
Alan Nurden, Emeritus Research Director at CNRS, Co-Founder of the French National Reference Centre for Inherited Platelet Disorders (CRPP), shared a post on LinkedIn about a recent article by Joanne L. Mitchell et al., published in Basic Research in Cardiology, adding:
“This provocative manuscript looks in depth at the effects of anti-platelet drugs and at inhibiting thrombin in the context of ischemia-reperfusion injury of the coronary microcirculation of wildtype and diabetic mice.
It comes some 25 years after the identification of the P2Y12 receptor for ADP by Hollopeter et al.
The authors provide insights into both the inhibition of platelet-rich thrombi formation and the potentially negative effects of increased neutrophil infiltration on cardiac damage and/or repair.
For me, this study emphasizes the need to look again at the molecular interactions that occur during thrombus formation under flow using the modern advances in immunofluorescent imaging as illustrated in the recent manuscript by Kusch et al.
I am thinking not only of primary platelet interactions with themselves and fibrin but also their role in thrombo-inflammation and neutrophil migration across the endothelial barrier into inflamed tissue.
We still have much to learn as this manuscript illustrates before truly optimal personalized combined therapies involving different drugs enter clinical practice. This article by Joanne Mitchell and her coworkers is highly recommended.”
1.Title: Comparing anti-platelet and anti-thrombin therapies in the ischaemia–reperfusion injured coronary microcirculation of healthy and diabetic mice
Authours: Joanne L. Mitchell, Juma El-Awaisi, Dean Kavanagh, Bernhard Nieswandt, Robert F. Storey and Neena Kalia
Read the Full Article on Basic Research in Cardiology
2.Title: Platelet-derived integrin- and tetraspanin-enriched tethers exacerbate severe inflammation
Auhtors: Charly Kusch, David Stegner, Lukas J Weiss, Paquita Nurden, Philipp Burkard, Denise Johnson, Wolfgang Bergmeier, Ceylan Onursal, Stefano Navarro, Christian Hackenbroch, Dennis Pfeiffer, Sabrina Ivana Bonfiglio, Mara Meub, Carina Gross, Joachim Schenk, Valeria Fumagalli, Kristina Mott, Markus Bender, Matteo Iannacone, Oliver Andres, Wolfgang Kastenmüller, Katrin G Heinze, Markus Sauer, Harald Schulze, Klaus Ley, Alan T Nurden, Bernhard Nieswandt
Read the Full Article on Science
Find more posts featuring Alan Nurden on Hemostasis Today.
-
Sep 4, 2026, 02:18Edgardo Alania: Edoxaban in Intracranial Haemorrhage Survivors with AF
-
Sep 3, 2026, 20:33Jennifer Weinstein: Happy to Share Our New Work on the Patient Experience in VWD at the NBDF Conference
-
Sep 3, 2026, 20:31Guillaume Courbon: New Publication on Erythroid-Produced FGF23 and Its Role in Anemia
-
Sep 3, 2026, 20:30Phuong Khanh Morrow: FDA Approval Marks an Important Step Forward for the PV Community
-
Sep 3, 2026, 20:29Sarah Robins: Happy to Share This Portrait Film I Voiced for the NNHHF
-
Sep 3, 2026, 20:27Mireille Muller: Europe Needs More Plasma Donors
-
Sep 3, 2026, 17:54Tareq Abadl: Extravascular Hemolysis The High-Yield Guide
-
Sep 3, 2026, 17:48Isabel Sá: Starting a New Chapter as a Clinical Scientist in Molecular Genetics and Haematology
-
Sep 3, 2026, 17:40Chiwoo Oh: AS01B Adjuvant and Long-Term Immune Reprogramming After Shingrix Vaccination